Fig. 3.
Serum levels of the biomarkers at 0, 4, and 12 weeks following AF onset in the control group and the candesartan group (A to D). AF: atrial fibrillation, TIMP-1: tissue inhibitor of matrix metalloproteinase-1.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.